Sally Yu Shi
Xalud Therapeutics (United States)(US)
Publications by Year
Research Areas
Adipokines, Inflammation, and Metabolic Diseases, Cell death mechanisms and regulation, Liver Disease Diagnosis and Treatment, Metabolism, Diabetes, and Cancer, Cardiac Fibrosis and Remodeling
Most-Cited Works
- → Regulation of Obesity-Related Insulin Resistance with Gut Anti-inflammatory Agents(2015)354 cited
- → Targeting immune–fibroblast cell communication in heart failure(2024)170 cited
- → DJ-1 links muscle ROS production with metabolic reprogramming and systemic energy homeostasis in mice(2015)83 cited
- → Nucleic Acid-Targeting Pathways Promote Inflammation in Obesity-Related Insulin Resistance(2016)74 cited
- → In Vivo Role of Focal Adhesion Kinase in Regulating Pancreatic β-Cell Mass and Function Through Insulin Signaling, Actin Dynamics, and Granule Trafficking(2012)74 cited
- → Hepatocyte-specific Deletion of Janus Kinase 2 (JAK2) Protects against Diet-induced Steatohepatitis and Glucose Intolerance(2012)71 cited
- → FAK signalling controls insulin sensitivity through regulation of adipocyte survival(2017)68 cited
- → Perforin Is a Novel Immune Regulator of Obesity-Related Insulin Resistance(2014)66 cited
- → Adipocyte-specific deficiency of Janus kinase (JAK) 2 in mice impairs lipolysis and increases body weight, and leads to insulin resistance with ageing(2014)65 cited
- → Genetic Variation of DKK3 May Modify Renal Disease Severity in ADPKD(2010)62 cited